CompletedNot Applicable

A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence

China90 participantsStarted 2021-02-04

Plain-language summary

This study will collect effectiveness and safety data on JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults based on real world data.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓Participant has chin retrusion seeking chin enhancement who have received or plan to receive VOLUX chin treatment in Hainan Boao Super Hospital.

What they're measuring

Change from Baseline in the Glabella-Subnasale-Pogonion (G-Sn-Pog) Angle

Timeframe: Baseline, Month 3

Trial details

NCT IDNCT04687046

SponsorAllergan

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More Chin Retrusion trials